Holdings

Rtw Investments, LP

As of Sep 30, 2026, Rtw Investments, LP reported 78 positions worth US$9.36B. Largest: Protagonist Therapeutics, Inc., argenx SE and CG Oncology, Inc. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Protagonist Therapeutics, Inc.5.06MUS$713Mno changeSep 30, 2026
argenx SE712KUS$682M+2,138Sep 30, 2026
CG Oncology, Inc.8.51MUS$604Mno changeSep 30, 2026
iRhythm Holdings, Inc.3.12MUS$354M+936KSep 30, 2026
Insmed Incorporated3.1MUS$353M−1.75MSep 30, 2026
Tango Therapeutics, Inc.14MUS$351M+148KSep 30, 2026
Erasca, Inc.22.4MUS$329M+4.5MSep 30, 2026
Spyre Therapeutics, Inc.3.69MUS$329M−560KSep 30, 2026
RadNet, Inc.4.63MUS$319M−216KSep 30, 2026
Tarsus Pharmaceuticals, Inc.3.48MUS$274M+127KSep 30, 2026